English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1872]
News [4284]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Researchers establish intracellular interaction network in breast cancer
Researchers establish intracellular interaction network in breast cancer
Inflammation a key to targeting pregnancy-associated breast cancer
Inflammation a key to targeting pregnancy-associated breast cancer
Weight linked to risk of second cancer after breast cancer
Weight linked to risk of second cancer after breast cancer
Mapping the paradigm shift of China's cancer burden for designing prevention strategies
Mapping the paradigm shift of China's cancer burden for designing prevention strategies
AACR 2021: Liquid biopsy augments MRI for predicting response to neoadjuvant treatment in patients with breast cancer
AACR 2021: Liquid biopsy augments MRI for predicting response to neoadjuvant treatment in patients with breast...
AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and thyroid cancers
AACR 2021: FDA-approved selpercatinib shows clinical benefits for RET fusion-positive cancers beyond lung and...
Configuring infrared spectroscopy tools to better detect breast cancer
Configuring infrared spectroscopy tools to better detect breast cancer
Blocking a protein could help overcome cancer resistance to PARP inhibitors
Blocking a protein could help overcome cancer resistance to PARP inhibitors
Fewer breast cancer cases between screening rounds with 3D-mammography
Fewer breast cancer cases between screening rounds with 3D-mammography
FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer
FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer
<1...9495969798...429>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top